These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 23274471)

  • 61. Treg vaccination in autoimmune type 1 diabetes.
    Serr I; Weigmann B; Franke RK; Daniel C
    BioDrugs; 2014 Feb; 28(1):7-16. PubMed ID: 23959795
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells.
    Kwan WH; van der Touw W; Paz-Artal E; Li MO; Heeger PS
    J Exp Med; 2013 Feb; 210(2):257-68. PubMed ID: 23382542
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease.
    Sather BD; Treuting P; Perdue N; Miazgowicz M; Fontenot JD; Rudensky AY; Campbell DJ
    J Exp Med; 2007 Jun; 204(6):1335-47. PubMed ID: 17548521
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus.
    Lin J; Yang L; Silva HM; Trzeciak A; Choi Y; Schwab SR; Dustin ML; Lafaille JJ
    Nat Commun; 2016 Feb; 7():10562. PubMed ID: 26923114
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.
    Frey DM; Droeser RA; Viehl CT; Zlobec I; Lugli A; Zingg U; Oertli D; Kettelhack C; Terracciano L; Tornillo L
    Int J Cancer; 2010 Jun; 126(11):2635-43. PubMed ID: 19856313
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Re-establishing immunological self-tolerance in autoimmune disease.
    Sakaguchi S; Powrie F; Ransohoff RM
    Nat Med; 2012 Jan; 18(1):54-8. PubMed ID: 22227673
    [No Abstract]   [Full Text] [Related]  

  • 67. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells.
    Klunker S; Chong MM; Mantel PY; Palomares O; Bassin C; Ziegler M; Rückert B; Meiler F; Akdis M; Littman DR; Akdis CA
    J Exp Med; 2009 Nov; 206(12):2701-15. PubMed ID: 19917773
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Critical co-stimulatory pathways in the stability of Foxp3+ Treg cell homeostasis in Type I diabetes.
    Kornete M; Piccirillo CA
    Autoimmun Rev; 2011 Dec; 11(2):104-11. PubMed ID: 21875694
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.
    Luo CT; Liao W; Dadi S; Toure A; Li MO
    Nature; 2016 Jan; 529(7587):532-6. PubMed ID: 26789248
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The regulation of FoxP3-expressing regulatory T cells.
    Haque R; Lei F; Xiong X; Song J
    Endocr Metab Immune Disord Drug Targets; 2011 Dec; 11(4):334-46. PubMed ID: 21696363
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy.
    Verhagen J; Wegner A; Wraith DC
    Immunology; 2015 Jun; 145(2):171-81. PubMed ID: 25716063
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Stabilizing human regulatory T cells for tolerance inducing immunotherapy.
    He X; Koenen HJ; Slaats JH; Joosten I
    Immunotherapy; 2017 Aug; 9(9):735-751. PubMed ID: 28771099
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
    Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
    J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antigen-induced regulatory T cells in autoimmunity.
    von Herrath MG; Harrison LC
    Nat Rev Immunol; 2003 Mar; 3(3):223-32. PubMed ID: 12658270
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Extrathymic generation of regulatory T cells--chances and challenges for prevention of autoimmune disease.
    Daniel C; von Boehmer H
    Adv Immunol; 2011; 112():177-213. PubMed ID: 22118409
    [TBL] [Abstract][Full Text] [Related]  

  • 76. mTOR signaling, Tregs and immune modulation.
    Chapman NM; Chi H
    Immunotherapy; 2014; 6(12):1295-311. PubMed ID: 25524385
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Exploring the controversial role of PI3K signalling in CD4
    Poli A; Fiume R; Mongiorgi S; Zaurito A; Sheth B; Vidalle MC; Hamid SA; Kimber S; Campagnoli F; Ratti S; Rusciano I; Faenza I; Manzoli L; Divecha N
    Adv Biol Regul; 2020 May; 76():100722. PubMed ID: 32362560
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of natural regulatory T cells in infection.
    Sanchez AM; Yang Y
    Immunol Res; 2011 Apr; 49(1-3):124-34. PubMed ID: 21116872
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Regulatory T Cells and Human Disease.
    Sakaguchi S; Mikami N; Wing JB; Tanaka A; Ichiyama K; Ohkura N
    Annu Rev Immunol; 2020 Apr; 38():541-566. PubMed ID: 32017635
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
    Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
    J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.